Supports significant weight loss
Studies show substantial reductions in body weight by targeting multiple metabolic pathways that regulate appetite and energy balance.

The next generation metabolic peptide
GLP-3 RT is a novel, multi-receptor agonist peptide that targets GIP, GLP-1, and glucagon receptors. It has been studied for its potential to support significant weight reduction, improve metabolic health, and enhance glycemic control.
$30.00
Key benefits
Studies show substantial reductions in body weight by targeting multiple metabolic pathways that regulate appetite and energy balance.
By activating GLP-1, GIP, and glucagon receptors, GLP-3 RT has been shown to improve blood sugar levels in research settings.
Improves lipid metabolism and increases energy expenditure, helping the body utilise energy more efficiently.
Acts on the brain-gut axis to reduce hunger and food intake, promoting a feeling of fullness.
Research indicates lowered fat mass while helping preserve lean muscle mass.
Associated with improvements in blood pressure, lipid profiles, and other cardiovascular risk factors in clinical research.
GLP-3 RT is studied for its potential in weight management, metabolic health, glycemic control, and overall wellness enhancement.
Research reference sheet

Supplied strictly for laboratory research.
These products are not intended for human or veterinary use.
Keep at 2-8 °C at all times after receipt.
Store in a cool, dark place away from direct light.
For educational and research purposes only. Not for human consumption. This is not medical advice — always do your own research and consult a qualified professional.